1-240827155-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001364886.1(RGS7):āc.627A>Gā(p.Thr209=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00179 in 1,613,618 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0083 ( 16 hom., cov: 32)
Exomes š: 0.0011 ( 15 hom. )
Consequence
RGS7
NM_001364886.1 synonymous
NM_001364886.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.874
Genes affected
RGS7 (HGNC:10003): (regulator of G protein signaling 7) Enables G-protein beta-subunit binding activity and GTPase activator activity. Involved in positive regulation of GTPase activity. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 1-240827155-T-C is Benign according to our data. Variant chr1-240827155-T-C is described in ClinVar as [Benign]. Clinvar id is 787765.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.874 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00833 (1269/152344) while in subpopulation AFR AF= 0.0274 (1140/41578). AF 95% confidence interval is 0.0261. There are 16 homozygotes in gnomad4. There are 594 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1269 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGS7 | NM_001364886.1 | c.627A>G | p.Thr209= | synonymous_variant | 10/19 | ENST00000440928.6 | NP_001351815.1 | |
LOC124904602 | XR_007067053.1 | n.155+2137T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGS7 | ENST00000440928.6 | c.627A>G | p.Thr209= | synonymous_variant | 10/19 | 1 | NM_001364886.1 | ENSP00000404399 |
Frequencies
GnomAD3 genomes AF: 0.00833 AC: 1268AN: 152226Hom.: 16 Cov.: 32
GnomAD3 genomes
AF:
AC:
1268
AN:
152226
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00241 AC: 607AN: 251478Hom.: 6 AF XY: 0.00189 AC XY: 257AN XY: 135916
GnomAD3 exomes
AF:
AC:
607
AN:
251478
Hom.:
AF XY:
AC XY:
257
AN XY:
135916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1614AN: 1461274Hom.: 15 Cov.: 30 AF XY: 0.00101 AC XY: 734AN XY: 727006
GnomAD4 exome
AF:
AC:
1614
AN:
1461274
Hom.:
Cov.:
30
AF XY:
AC XY:
734
AN XY:
727006
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00833 AC: 1269AN: 152344Hom.: 16 Cov.: 32 AF XY: 0.00797 AC XY: 594AN XY: 74498
GnomAD4 genome
AF:
AC:
1269
AN:
152344
Hom.:
Cov.:
32
AF XY:
AC XY:
594
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
27
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at